Contact this trialFirst, we need to learn more about you.
Immunomodulator
TOL-3021 +1 More for Type 1 Diabetes
Recruiting0 awardsPhase 2
San Francisco, California
This trial tests TOL-3021, a muscle injection, in people aged 12 to under 41 who have had Type 1 Diabetes for less than 5 years. The goal is to see if it helps control their blood sugar levels better.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service